E-Cadherin、CD31在大肠癌中的表达及意义
Expression and Significance of E-Cadherin and CD31 in Colorectal Cancer
DOI: 10.12677/JPS.2018.64004, PDF,    国家自然科学基金支持
作者: 孙红梅：内蒙古科技大学包头医学院研究生学院，内蒙古 包头；武金宝*：包头医学院第二附属医院内蒙古消化病研究所，内蒙古 包头
关键词: 大肠癌；E-cadherin；CD31；Colorectal Cancer； E-Cadherin； CD31
摘要: 大肠癌(Colorectal cancer, CRC)是最常见的恶性肿瘤之一。转移及浸润在大肠癌发生、发展过程中起着重要的作用，E-cadherin、CD31与大肠癌的转移、浸润、肿瘤分期、疾病进展及预后相关。本文就这两种蛋白在大肠癌中的表达及意义展开诉述。
Abstract: Colorectal cancer (CRC) is one of the most common malignancies. Metastasis and infiltration play an important role in the development and progression of colorectal cancer. E-cadherin and CD31 are associated with metastasis, invasion, tumor staging, disease progression, and prognosis of colorectal cancer. This article describes the expression and significance of these two proteins in colorectal cancer.
文章引用：孙红梅, 武金宝. E-Cadherin、CD31在大肠癌中的表达及意义[J]. 生理学研究, 2018, 6(4): 21-26. https://doi.org/10.12677/JPS.2018.64004

参考文献

[1] Pudenz, M., et al. (2014) Impact of Soy Isoflavones on the Epigenome in Cancer Prevention. Nutrients, 6, 4218-4272. [Google Scholar] [CrossRef] [PubMed]
[2] 韩英, 李世荣, 盛剑秋. 开展大肠肿瘤“伺机性筛查”提高早诊早治水平[J]. 胃肠病学和肝病学杂志, 2010, 19(7): 581-583.
[3] 孙才坚, 姚淇, 徐静罡, 郁宝铭. 社区大肠癌因症就诊早发现及监测的前瞻性研究[J]. 中国肿瘤, 2004, 13(4): 201-203.
[4] Kwiatkowski, P., Godlewski, J., Śliwińska-Jewsiewicka, A., et al. (2009) Cell Adhesion Molecules in the Process of Carcinogenesis and Metastasis. Polish Annals of Medicine, 16, 128-137.
[5] Paschos, K.A., Canovas, D. and Bird, N.C. (2009) The Role of Cell Adhesion Molecules in the Progression of Colorectal Cancer and the Development of Liver Metastasis. Cellular Signalling, 21, 665-674. [Google Scholar] [CrossRef] [PubMed]
[6] Kouso, H., Yano, T., Maruyama, R., et al. (2013) Differences in the Expression of Epithelial-Mesenchymal Transition Related Molecules between Primary Tumors and Pulmonary Metastatic Tumors in Colorectal Cancer. Surgery Today, 43, 73-80. [Google Scholar] [CrossRef] [PubMed]
[7] Saad, R.S., El-Gohary, Y.L., Memari, E., Liu, Y.L. and Silverman, J.F. (2005) Endoglin (CD105) and Vascular Endothelial Growth Factor as Prognostic Markers in Esophageal Adenocarcinoma. Human Pathology, 36, 955-961. [Google Scholar] [CrossRef] [PubMed]
[8] 李真. Hsa-miR-506-3p靶向ERK-2/ETS-1抑制胃癌血管新生及侵袭转移的功能及机制研究[D]: [博士学位论文]. 广州: 南方医科大学, 2016.
[9] 薛淑萍. VASH1、MVD在NSCLC中的表达及意义[D]: [硕士学位论文]. 乌鲁木齐: 新疆医科大学, 2016.
[10] 贾玉峰. 微血管密度对食管鳞状细胞癌预后的价值[J]. 中国社区医师, 2015, 31(31): 81-83.
[11] 赖春凤, 程纬民. 血管内皮生长因子及血小板源生长因子家族与肺癌转移及预后关系的研究进展[J]. 广西医学, 2015, 37(9): 1305-1308.
[12] 李建国, 马国章, 杨志伟, 等. CD31和Ki-67在大肠癌组织中的表达和相关性研究[J]. 中国误诊学杂志, 2004, 1(4): 22-24.
[13] Berx, G., Staes, K., van Hengel, J., et al. (1995) Cloning and Characterization of the Hu-man Invasion Suppressor Gene E-Cadherin (CDH1). Genomics, 26, 281-289. [Google Scholar] [CrossRef] [PubMed]
[14] 张志发, 严群, 黄志勇. 钻附分子Cadherin与肝癌生物学特性的关系[J]. 世界华人消化杂志, 2006, 14(7): 697-701.
[15] Newman, P.J., Berndt, M.C., Gorski, J., et al. (1990) PECAM-1 (CD31) Cloning and Relation to Adhesion Molecules of the Immunoglobulin Gene Superfamily. Science, 247, 1219-1222. [Google Scholar] [CrossRef] [PubMed]
[16] Newton, J.P., Hunter, A.P., Simmons, D.L., et al. (1999) CD31 (PECAM-1) Exists as a Dimer and Is Heavily N-Glycosylated. Biochemical and Biophysical Research Communications, 261, 283-291. [Google Scholar] [CrossRef] [PubMed]
[17] Paddock, C., Zhou, D., Lertkiatmongkol, P., et al. (2016) Structural Basis for PECAM-1 Homophilic Binding. Blood, 127, 1052-1061. [Google Scholar] [CrossRef] [PubMed]
[18] Cao, G., O’Brien, C.D., Zhou, Z., et al. (2002) Involvement of Human PECAM-1 in Angiogenesis and in Vitro Endothelial Cell Migration. American Journal of Physiology—Cell Physiology, 282, C1181-C1190.
[19] Lim, J. and Thiery, J.P. (2012) Epithelial-Mesenchymal Transitions: Insights from Development. Development, 139, 3471-3486. [Google Scholar] [CrossRef] [PubMed]
[20] Buda, A. and Pignatelli, M. (2011) E-Cadherin and the Cytoskeletal Network in Colorectal Cancer Development and Metastasis. Cell Communication & Adhesion, 18, 133-143.
[21] Li, N., Chen, X.B., Wan, X.B., et al. (2008) Relationship between Expression of CEA, E-Cadherin and Liver Metas-tasis in Colorectal Cancer. Chinese Journal of Clinical Oncology, 5, 429-432.
[22] Fiocca, R., Luinetti, O., Villani, L., et al. (2001) Molecular Mechanisms Involved in the Pathogenesis of Gastric Carcinoma: Interactions between Genetic Alterations, Cellular Phe-notype and Cancer Histotype. Hepatogastroenterology, 48, 1523-1530.
[23] Cepowicz, D., Zareba, K., Pryczynicz, A., et al. (2017) Blood Serum Levels of E-Cadherin in Patients with Colorectal Cancer. Original Paper, 12, 186-191.
[24] 骆赞. Foxq1与E-cadherin蛋白在大肠癌中的表达及临床意义[D]: [硕士学位论文]. 重庆: 重庆医科大学, 2014.
[25] 隋立荣, 吕英志, 孙立斌, 王谦, 杨凤英, 李沈一. 应用组织芯片研究E-cadherin在大肠癌的表达[J]. 中国病理生理杂志, 2007(7): 1439-1441.
[26] 钟宝元, 刘清泉, 等. STAT3及其磷酸化STAT3和E钙黏蛋白在结直肠癌组织中的表达及意义[J]. 中华胃肠外科杂志, 2014, 17(6): 594-597.
[27] Piura, B., Rabinovieh, A., Aizenberg, N. and Wolfson, M. (2005) Cadherins in Malignaneies of the Female Genital Tracta. Horefah, 14, 261-265.
[28] 王红建, 史成章, 秦先锋, 黄秋实. Ezrin/FAK及E-cadherin在大肠癌组织中的表达及其临床意义[J]. 世界华人消化杂志, 2007(6): 591-595.
[29] Kanazawa, N., Oda, T., Gunji, N., et al. (2002) E-cadherin Expression in the Primary Tumors and Met Astatic Lymph Nodes of Poorly Differentiated Types of Rectal Cancer. Surgery Today, 32, 123. [Google Scholar] [CrossRef] [PubMed]
[30] Park, S., DiMaio, T.A., Scheef, E.A., et al. (2010) PECAM1 Regulates Proangiogenic Properties of Endothelial Cells through Modulation of Cell and Cell Matrix Interactions. American Journal of Physiology—Cell Phy-siology, 299, C1468-C1484.
[31] Yang, L., Guan, H., He, J., Zeng, L., et al. (2012) VEGF Increases the Proliferative Capacity and eNOS/NO Levels of Endothelial Progenitor Cells through the Calcineurin/NFAT Signaling Pathway. Cell Biology International, 36, 2127.
[32] 王保才. Lgr5对结直肠肿瘤血管生成的影响及其机制研究[D]: [硕士学位论文]. 广州市: 南方医科大学, 2011.
[33] 黄礼年. 血管内皮生长因子与人非小细胞肺癌的相关性研究[D]: [博士学位论文]. 济南市: 山东大学, 2010.
[34] 赵建华. 血管生成与肿瘤转移[J]. 中国实验诊断学, 2001(4): 201-204.
[35] 袁梅琴, 钟海均. 血小板内皮细胞黏附分子-1 (PECAM-1)与肿瘤关系研究进展[J]. 海峡药学, 2016, 10(28): 6-8.
[36] Chung, J., Braunschweig, T., Hong, S., et al. (2014) Assessment of Vas-cular Endothelial Growth Factor in Formalin Fixed, Paraffin-Embedded Colon Cancer Specimens Using a Well-Based Reverse Phase Protein Array. Proteome Science, 12, 27. [Google Scholar] [CrossRef] [PubMed]
[37] Cammarota, R., Bertolini, V. and Penne, G. (2010) The Tumor Microenvironment of Colorectal Cancer: Stromal TLR-4 Expression as a Potential Prognostic Marker. Journal of Translational Medicine, 8, 112. [Google Scholar] [CrossRef] [PubMed]
[38] Tien, Y.W., Chang, K.J., Jeng, M., et al. (2001) Tumor Angiogenesis and Its Possible Role in Intravasation of Colorectal Epithelial Cells. Clinical Cancer Research, 7, 1627-1632.
[39] Salem, Y.M., Hanan, L.M., Hanaa, M.I., et al. (2017) Role of VEGF, CD105, and CD31 in the Prognosis of Colorectal Cancer Cases. Journal of Gastrointestinal Cancer. [Google Scholar] [CrossRef] [PubMed]
[40] Sun, W., Dou, J., Zhang, L., et al. (2017) Expression of CD133, E-cadherin and WWOX in Colorectal Cancer and Related Analysis. Pakistan Journal of Medical Sciences, 2, 245-249.
[41] Palaghia, M., Mihai, C., Lozneanu, L., Ciobanu, D., Trofin, A.M., Rotariu, A., et al. (2016) E-cadherin Expression in Primary Colorectal Cancer and Metastatic Lymph Nodes. Romanian Journal of Morphology and Embryology, 57, 205-209.
[42] 秦乐, 曾妍. E-cadherin缺失表达与结直肠癌患者预后相关性多元Cox回归分析[J]. 中国临床药理学杂志, 2017, 33(1): 7-9.
[43] 马思平, 单吉贤, 王辉. E-cadherin和β-catenin在大肠癌组织中的表达及与预后的关系[J]. 实用肿瘤学杂志, 2003, 17(4): 268-270.
[44] 高钧, 孙燕, 赵秀兰, 等. NGALMMP-9和E-cadherin在结肠癌中的表达及其与预后的关系[J]. 中国肿瘤临床, 2011, 38(6): 324-327.
[45] Des Guetz, G., Uzzan, B., Nicolas, P., et al. (2006) Microvessel Density and VEGF Expression Are Prognostic Fac-tors in Colorectal Cancer. British Journal of Cancer, 94, 1823-1832. [Google Scholar] [CrossRef] [PubMed]
[46] 张莎莎, 冯一中. 大肠腺癌中微血管密度和Ki67表达及其临床意义[J]. 江苏医药, 2011, 37(11): 1266-1269.
[47] 杨琳, 郭宝文, 赵魁. IGF-II和IGF-IR在大肠癌中的表达[J]. 山东医药, 2005, 10(9): 8-10.

为你推荐